腫瘍学バイオマーカーの世界市場 2019年版：種類別（肺がん、乳がん、大腸がん、前立腺がん、胃がん、その他）、用途別（診断、創薬＆開発、予後、リスクアセスメント、その他）

• 英文タイトル：Global Oncology Biomarker Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：C-GIR20G2909 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

「腫瘍学バイオマーカーの世界市場2019年」は、グローバルにおける腫瘍学バイオマーカー市場を展望するレポートです。腫瘍学バイオマーカーのグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・腫瘍学バイオマーカーの市場概観 ・腫瘍学バイオマーカーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腫瘍学バイオマーカーの企業別販売動向、市場シェア、市場集中度、競争動向 ・腫瘍学バイオマーカーの世界市場規模 ・腫瘍学バイオマーカーの北米市場分析（アメリカ、カナダ、メキシコ等） ・腫瘍学バイオマーカーのアメリカ市場規模推移 ・腫瘍学バイオマーカーのカナダ市場規模推移 ・腫瘍学バイオマーカーのメキシコ市場規模推移 ・腫瘍学バイオマーカーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・腫瘍学バイオマーカーのドイツ市場規模推移 ・腫瘍学バイオマーカーのイギリス市場規模推移 ・腫瘍学バイオマーカーのロシア市場規模推移 ・腫瘍学バイオマーカーのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・腫瘍学バイオマーカーの日本市場規模推移 ・腫瘍学バイオマーカーの中国市場規模推移 ・腫瘍学バイオマーカーの韓国市場規模推移 ・腫瘍学バイオマーカーのインド市場規模推移 ・腫瘍学バイオマーカーの東南アジア市場規模推移 ・腫瘍学バイオマーカーの南米市場分析（ブラジル、アルゼンチン等） ・腫瘍学バイオマーカーの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・腫瘍学バイオマーカーの種類別分析/販売量、売上、市場シェア（肺がん、乳がん、大腸がん、前立腺がん、胃がん、その他） ・腫瘍学バイオマーカーの用途別分析/市場規模（診断、創薬＆開発、予後、リスクアセスメント、その他） ・腫瘍学バイオマーカーの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・腫瘍学バイオマーカーの販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Oncology Biomarker market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oncology Biomarker.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Oncology Biomarker market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oncology Biomarker market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novartis AG
Merck & Co.
F.Hoffmann-La Roche Ltd.
Bristol-Myers Squibb
Abbott Laboratories
Eli Lilly and Company
Qiagen N.V.
GlaxoSmithKline plc
Genomic Health
Pfizer

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Stomach Cancer
Others

Market Segment by Applications, can be divided into
Diagnostics
Drug Discovery And Development
Prognostics
Risk Assessment
Others

レポート目次

---

Table of Contents

1 Oncology Biomarker Market Overview
1.1 Product Overview and Scope of Oncology Biomarker
1.2 Classification of Oncology Biomarker by Types
1.2.1 Global Oncology Biomarker Revenue Comparison by Types (2019-2024)
1.2.2 Global Oncology Biomarker Revenue Market Share by Types in 2018
1.2.3 Lung Cancer
1.2.4 Breast Cancer
1.2.5 Colorectal Cancer
1.2.6 Prostate Cancer
1.2.7 Stomach Cancer
1.2.8 Others
1.3 Global Oncology Biomarker Market by Application
1.3.1 Global Oncology Biomarker Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Diagnostics
1.3.3 Drug Discovery And Development
1.3.4 Prognostics
1.3.5 Risk Assessment
1.3.6 Others
1.4 Global Oncology Biomarker Market by Regions
1.4.1 Global Oncology Biomarker Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Oncology Biomarker Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Oncology Biomarker Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Biomarker Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Oncology Biomarker Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Biomarker Status and Prospect (2014-2024)
1.5 Global Market Size of Oncology Biomarker (2014-2024)
2 Company Profiles
2.1 Novartis AG
2.1.1 Business Overview
2.1.2 Oncology Biomarker Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis AG Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck & Co.
2.2.1 Business Overview
2.2.2 Oncology Biomarker Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co. Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.3 F.Hoffmann-La Roche Ltd.
2.3.1 Business Overview
2.3.2 Oncology Biomarker Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Oncology Biomarker Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott Laboratories
2.5.1 Business Overview
2.5.2 Oncology Biomarker Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Laboratories Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.6 Eli Lilly and Company
2.6.1 Business Overview
2.6.2 Oncology Biomarker Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Eli Lilly and Company Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.7 Qiagen N.V.
2.7.1 Business Overview
2.7.2 Oncology Biomarker Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Qiagen N.V. Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.8 GlaxoSmithKline plc
2.8.1 Business Overview
2.8.2 Oncology Biomarker Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GlaxoSmithKline plc Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.9 Genomic Health
2.9.1 Business Overview
2.9.2 Oncology Biomarker Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genomic Health Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Oncology Biomarker Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
3 Global Oncology Biomarker Market Competition, by Players
3.1 Global Oncology Biomarker Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Biomarker Players Market Share
3.2.2 Top 10 Oncology Biomarker Players Market Share
3.3 Market Competition Trend
4 Global Oncology Biomarker Market Size by Regions
4.1 Global Oncology Biomarker Revenue and Market Share by Regions
4.2 North America Oncology Biomarker Revenue and Growth Rate (2014-2019)
4.3 Europe Oncology Biomarker Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Oncology Biomarker Revenue and Growth Rate (2014-2019)
4.5 South America Oncology Biomarker Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Oncology Biomarker Revenue and Growth Rate (2014-2019)
5 North America Oncology Biomarker Revenue by Countries
5.1 North America Oncology Biomarker Revenue by Countries (2014-2019)
5.2 USA Oncology Biomarker Revenue and Growth Rate (2014-2019)
5.3 Canada Oncology Biomarker Revenue and Growth Rate (2014-2019)
5.4 Mexico Oncology Biomarker Revenue and Growth Rate (2014-2019)
6 Europe Oncology Biomarker Revenue by Countries
6.1 Europe Oncology Biomarker Revenue by Countries (2014-2019)
6.2 Germany Oncology Biomarker Revenue and Growth Rate (2014-2019)
6.3 UK Oncology Biomarker Revenue and Growth Rate (2014-2019)
6.4 France Oncology Biomarker Revenue and Growth Rate (2014-2019)
6.5 Russia Oncology Biomarker Revenue and Growth Rate (2014-2019)
6.6 Italy Oncology Biomarker Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Oncology Biomarker Revenue by Countries
7.1 Asia-Pacific Oncology Biomarker Revenue by Countries (2014-2019)
7.2 China Oncology Biomarker Revenue and Growth Rate (2014-2019)
7.3 Japan Oncology Biomarker Revenue and Growth Rate (2014-2019)
7.4 Korea Oncology Biomarker Revenue and Growth Rate (2014-2019)
7.5 India Oncology Biomarker Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Oncology Biomarker Revenue and Growth Rate (2014-2019)
8 South America Oncology Biomarker Revenue by Countries
8.1 South America Oncology Biomarker Revenue by Countries (2014-2019)
8.2 Brazil Oncology Biomarker Revenue and Growth Rate (2014-2019)
8.3 Argentina Oncology Biomarker Revenue and Growth Rate (2014-2019)
8.4 Colombia Oncology Biomarker Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Oncology Biomarker by Countries
9.1 Middle East and Africa Oncology Biomarker Revenue by Countries (2014-2019)
9.2 Saudi Arabia Oncology Biomarker Revenue and Growth Rate (2014-2019)
9.3 UAE Oncology Biomarker Revenue and Growth Rate (2014-2019)
9.4 Egypt Oncology Biomarker Revenue and Growth Rate (2014-2019)
9.5 Nigeria Oncology Biomarker Revenue and Growth Rate (2014-2019)
9.6 South Africa Oncology Biomarker Revenue and Growth Rate (2014-2019)
10 Global Oncology Biomarker Market Segment by Type
10.1 Global Oncology Biomarker Revenue and Market Share by Type (2014-2019)
10.2 Global Oncology Biomarker Market Forecast by Type (2019-2024)
10.3 Lung Cancer Revenue Growth Rate (2014-2024)
10.4 Breast Cancer Revenue Growth Rate (2014-2024)
10.5 Colorectal Cancer Revenue Growth Rate (2014-2024)
10.6 Prostate Cancer Revenue Growth Rate (2014-2024)
10.7 Stomach Cancer Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Oncology Biomarker Market Segment by Application
11.1 Global Oncology Biomarker Revenue Market Share by Application (2014-2019)
11.2 Oncology Biomarker Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2014-2019)
11.4 Drug Discovery And Development Revenue Growth (2014-2019)
11.5 Prognostics Revenue Growth (2014-2019)
11.6 Risk Assessment Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Oncology Biomarker Market Size Forecast (2019-2024)
12.1 Global Oncology Biomarker Market Size Forecast (2019-2024)
12.2 Global Oncology Biomarker Market Forecast by Regions (2019-2024)
12.3 North America Oncology Biomarker Revenue Market Forecast (2019-2024)
12.4 Europe Oncology Biomarker Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Oncology Biomarker Revenue Market Forecast (2019-2024)
12.6 South America Oncology Biomarker Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Oncology Biomarker Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Oncology Biomarker Picture
Table Product Specifications of Oncology Biomarker
Table Global Oncology Biomarker and Revenue (Million USD) Market Split by Product Type
Figure Global Oncology Biomarker Revenue Market Share by Types in 2018
Figure Lung Cancer Picture
Figure Breast Cancer Picture
Figure Colorectal Cancer Picture
Figure Prostate Cancer Picture
Figure Stomach Cancer Picture
Figure Others Picture
Table Global Oncology Biomarker Revenue (Million USD) by Application (2014-2024)
Figure Oncology Biomarker Revenue Market Share by Applications in 2018
Figure Diagnostics Picture
Figure Drug Discovery And Development Picture
Figure Prognostics Picture
Figure Risk Assessment Picture
Figure Others Picture
Table Global Market Oncology Biomarker Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Oncology Biomarker Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Oncology Biomarker Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Oncology Biomarker Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Oncology Biomarker Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Oncology Biomarker Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Oncology Biomarker Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Oncology Biomarker Type and Applications
Table Novartis AG Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Oncology Biomarker Type and Applications
Table Merck & Co. Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table F.Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F.Hoffmann-La Roche Ltd. Oncology Biomarker Type and Applications
Table F.Hoffmann-La Roche Ltd. Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Oncology Biomarker Type and Applications
Table Bristol-Myers Squibb Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Oncology Biomarker Type and Applications
Table Abbott Laboratories Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly and Company Oncology Biomarker Type and Applications
Table Eli Lilly and Company Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table Qiagen N.V. Oncology Biomarker Type and Applications
Table Qiagen N.V. Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Oncology Biomarker Type and Applications
Table GlaxoSmithKline plc Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Genomic Health Basic Information, Manufacturing Base and Competitors
Table Genomic Health Oncology Biomarker Type and Applications
Table Genomic Health Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Oncology Biomarker Type and Applications
Table Pfizer Oncology Biomarker Revenue, Gross Margin and Market Share (2017-2018)
Table Global Oncology Biomarker Revenue (Million USD) by Players (2014-2019)
Table Global Oncology Biomarker Revenue Share by Players (2014-2019)
Figure Global Oncology Biomarker Revenue Share by Players in 2017
Figure Global Oncology Biomarker Revenue Share by Players in 2018
Figure Global Top 5 Players Oncology Biomarker Revenue Market Share in 2018
Figure Global Top 10 Players Oncology Biomarker Revenue Market Share in 2018
Figure Global Oncology Biomarker Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Oncology Biomarker Revenue (Million USD) by Regions (2014-2019)
Table Global Oncology Biomarker Revenue Market Share by Regions (2014-2019)
Figure Global Oncology Biomarker Revenue Market Share by Regions (2014-2019)
Figure Global Oncology Biomarker Revenue Market Share by Regions in 2018
Figure North America Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Europe Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure South America Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Oncology Biomarker Revenue and Growth Rate (2014-2019)
Table North America Oncology Biomarker Revenue by Countries (2014-2019)
Table North America Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure North America Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure North America Oncology Biomarker Revenue Market Share by Countries in 2018
Figure USA Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Canada Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Mexico Oncology Biomarker Revenue and Growth Rate (2014-2019)
Table Europe Oncology Biomarker Revenue (Million USD) by Countries (2014-2019)
Figure Europe Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure Europe Oncology Biomarker Revenue Market Share by Countries in 2018
Figure Germany Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure UK Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure France Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Russia Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Italy Oncology Biomarker Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Oncology Biomarker Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Oncology Biomarker Revenue Market Share by Countries in 2018
Figure China Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Japan Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Korea Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure India Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Oncology Biomarker Revenue and Growth Rate (2014-2019)
Table South America Oncology Biomarker Revenue by Countries (2014-2019)
Table South America Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure South America Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure South America Oncology Biomarker Revenue Market Share by Countries in 2018
Figure Brazil Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Argentina Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Colombia Oncology Biomarker Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Oncology Biomarker Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oncology Biomarker Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Oncology Biomarker Revenue Market Share by Countries in 2018
Figure Saudi Arabia Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure UAE Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Egypt Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure Nigeria Oncology Biomarker Revenue and Growth Rate (2014-2019)
Figure South Africa Oncology Biomarker Revenue and Growth Rate (2014-2019)
Table Global Oncology Biomarker Revenue (Million USD) by Type (2014-2019)
Table Global Oncology Biomarker Revenue Share by Type (2014-2019)
Figure Global Oncology Biomarker Revenue Share by Type (2014-2019)
Figure Global Oncology Biomarker Revenue Share by Type in 2018
Table Global Oncology Biomarker Revenue Forecast by Type (2019-2024)
Figure Global Oncology Biomarker Market Share Forecast by Type (2019-2024)
Figure Global Lung Cancer Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Colorectal Cancer Revenue Growth Rate (2014-2019)
Figure Global Prostate Cancer Revenue Growth Rate (2014-2019)
Figure Global Stomach Cancer Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Oncology Biomarker Revenue by Application (2014-2019)
Table Global Oncology Biomarker Revenue Share by Application (2014-2019)
Figure Global Oncology Biomarker Revenue Share by Application (2014-2019)
Figure Global Oncology Biomarker Revenue Share by Application in 2018
Table Global Oncology Biomarker Revenue Forecast by Application (2019-2024)
Figure Global Oncology Biomarker Market Share Forecast by Application (2019-2024)
Figure Global Diagnostics Revenue Growth Rate (2014-2019)
Figure Global Drug Discovery And Development Revenue Growth Rate (2014-2019)
Figure Global Prognostics Revenue Growth Rate (2014-2019)
Figure Global Risk Assessment Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Oncology Biomarker Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Oncology Biomarker Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Oncology Biomarker Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Oncology Biomarker Revenue Market Forecast (2019-2024)
Figure Europe Oncology Biomarker Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Oncology Biomarker Revenue Market Forecast (2019-2024)
Figure South America Oncology Biomarker Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Oncology Biomarker Revenue Market Forecast (2019-2024)

---